Stock Comparison
REGN vs VRTX
Regeneron Pharmaceuticals Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$66.35B
$124.70B
P/E (TTM)
15.5
29.2
Forward P/E
14.1
25.8
Price/Sales
4.5
10.2
Price/Book
2.1
6.4
EV/EBITDA
10.5
24.0
Dividend Yield
0.58%
—
Profitability
Net Margin
29.60%
35.50%
Operating Margin
20.70%
38.10%
Return on Equity
14.50%
24.20%
Return on Assets
6.13%
12.10%
Growth (YoY)
Revenue Growth
19.00%
7.80%
Earnings Growth
-7.20%
61.40%
Price & Risk
Beta
0.2
0.3
52-Week High
$818.90
$507.92
52-Week Low
$516.07
$362.50
Analyst Target
$833.31
$548.69
Compare REGN and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.